Mj. Cross et L. Claesson-welsh, FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition, TRENDS PHAR, 22(4), 2001, pp. 201-207
Angiogenic growth factors such as fibroblast growth factors (FGFs) and vasc
ular endothelial growth factors (VEGFs) are currently targets of intense ef
forts to inhibit deregulated blood vessel formation in diseases such as can
cer. FGFs and VEGFs exert their effects via specific binding to cell surfac
e-expressed receptors equipped with tyrosine kinase activity, Activation of
the receptor kinase activity allows coupling to downstream signal transduc
tion pathways that regulate proliferation, migration and differentiation of
endothelial cells. Inhibitors of For and VEGF signalling are currently in
clinical trials. In this article, the current knowledge of FGF- and VEGF-in
duced signal transduction that leads to specific biological responses will
be summarized. Furthermore, the manner in which this knowledge is being exp
loited to regulate angiogenesis will be discussed.